Literature DB >> 849674

Pharmacokinetics of chlorpromazine after single and chronic dosage.

S G Dahl, R E Strandjord.   

Abstract

Plasma concentrations of chlorpromazine and its sulfoxide were measured after single intramuscular, single oral, and multiple oral doses of chlorpromazine. In four out of nine patients, intramuscular doses gave stable chlorpromazine plasma levels which were maintained for 12 hr or longer. Chlorpromazine sulfoxide was found in plasma from all patients after oral doses but not after intramuscular doses, which indicates that sulfoxidation took place presystemically. The biologic availability of single oral doses relative to single intramuscular doses ranged from 10 to 69%, and was on average 32%. After 33 days of oral dosing, the plasma levels of chlorpromazine were on average 37% lower than might have been predicted from the single oral dose curves. This was not due to decreased biologic t 1/2 of chlorpromazine, but apparently to a decrease in the biologic availability by oral administration, possibly by increased presystemic metabolism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849674     DOI: 10.1002/cpt1977214437

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  26 in total

1.  Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions.

Authors:  John T Barr; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2011-09-22       Impact factor: 3.922

2.  Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine.

Authors:  P Arlock; B Gullberg; S R Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

Review 3.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 4.  Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications.

Authors:  S R Marder; J W Hubbard; T Van Putten; K K Midha
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Ventilatory stimulation by dopamine-receptor antagonists in the mouse.

Authors:  L G Olson; N A Saunders
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

Review 6.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

7.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

8.  Effect of diazepam and chlorpromazine on memory functions in man.

Authors:  R Liljequist; M Linnoila; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

9.  Structural changes by sulfoxidation of phenothiazine drugs.

Authors:  S G Dahl; P A Kollman; S N Rao; U C Singh
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

10.  Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.

Authors:  B M Cohen; T Tsuneizumi; R J Baldessarini; A Campbell; S M Babb
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.